Skip to main navigation
Skip to search
Skip to main content
Houston Methodist Scholars Home
Home
Experts
Research units
Cores
Projects
Research output
Prizes
Search by expertise, name or affiliation
Topographic Correspondence of Macular Atrophy With Choroidal Neovascularization in Ranibizumab-treated Eyes of the TREX-AMD Trial
TREX-AMD Study Group
Academic Institute
Department of Ophthalmology-Blanton Eye Institute
Houston Methodist Hospital
Houston Methodist
Weill Cornell Medical College
Research output
:
Contribution to journal
›
Article
›
peer-review
8
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Topographic Correspondence of Macular Atrophy With Choroidal Neovascularization in Ranibizumab-treated Eyes of the TREX-AMD Trial'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Choroidal Neovascularization
100%
Writing
100%
Macular Degeneration
100%
Ranibizumab
100%
Wet Macular Degeneration
14%
Fluorescein Angiography
9%
Autofluorescence
9%
Post-Hoc Analysis
4%
Controlled Clinical Trial
4%
Spectral Domain Optical Coherence Tomography
4%
Nursing and Health Professions
Subretinal Neovascularization
100%
Ranibizumab
100%
Macular Degeneration
100%
Wet Macular Degeneration
14%
Fluorescence Angiography
9%
Post Hoc Analysis
4%
Spectral Domain Optical Coherence Tomography
4%
Pharmacology, Toxicology and Pharmaceutical Science
Subretinal Neovascularization
100%
Ranibizumab
100%
Macular Degeneration
100%
Wet Macular Degeneration
14%
Fluorescein
9%
Controlled Clinical Trial
4%
Keyphrases
Type 1 Choroidal Neovascularization
5%